Breaking News Instant updates and real-time market news.

NFLX

Netflix

$363.01

-2.71 (-0.74%)

16:13
07/17/19
07/17
16:13
07/17/19
16:13

Netflix down 11% in afterhours after Q2 net subscriber adds miss forecast

Netflix shares are down $38.54, or 10.6%, to $323.90 at time of writing.

  • 17

    Jul

  • 17

    Jul

NFLX Netflix
$363.01

-2.71 (-0.74%)

07/12/19
FBCO
07/12/19
NO CHANGE
Target $450
FBCO
Outperform
Netflix app download trends weakened 'dramatically' in Q2, say Credit Suisse
Credit Suisse analyst Douglas Mitchelson tells investors in a research note that Netflix app download trends weakened dramatically in the second quarter, with global downloads up 8% year-over-year vs. an increase of 24% y/y in the first quarter, driven by price increases and was anticipated in guidance. Mitchelson, who maintains an Outperform rating, $450 price target and second quarter estimates, notes downside risk and little upside potential for Q2 international net adds.
07/15/19
KEYB
07/15/19
NO CHANGE
KEYB
Sector Weight
KeyBanc expects Netflix to report in-line results, guidance
Ahead of Netflix's quarterly results, KeyBanc analyst Andy Hargreaves expects modest upside to Q2 guidance and Q3 subscriber guidance that is largely in line with current sell-side expectations. While the analyst sees the potential for some upside to this expectation, he maintains the magnitude of upside is likely to be limited, which is likely to prevent material near-term stock appreciation. Hargreaves has a Sector Weight rating on the shares.
07/16/19
MSCO
07/16/19
NO CHANGE
Target $450
MSCO
Overweight
Netflix price increases support healthy ARPU growth, says Morgan Stanley
In a preview of the upcoming earnings report from Netflix, Morgan Stanley analyst Benjamin Swinburne said he expects the company to again deliver record net additions in FY19 and near double digit ARPU growth supported by its recent price increases. He remains in-line with guidance for 300,000 U.S. paid net adds and 4.7M international net adds in Q2 and raised his Q3 revenue and earnings estimates for more international price increases than he'd previously expected. Swinburne keeps an Overweight rating and $450 price target on Netflix shares.
07/17/19
LYNX
07/17/19
NO CHANGE
LYNX
Key for Netflix earnings is International subscriber guidance, says Lynx
Lynx Equity Strategies analysts KC Rajkumar and Jahanara Nissar said ahead of Netflix's Q2 earnings that the key for the company's earnings report is the Q3 International subscriber guidance, noting that investors are looking for 5.5M or better for the stock to go higher, and "anything less may result in a flattish stock performance over the next week." The analysts suggest to "wait this one out."

TODAY'S FREE FLY STORIES

HAL

Halliburton

$19.60

1.16 (6.29%)

07:55
10/22/19
10/22
07:55
10/22/19
07:55
Recommendations
Halliburton analyst commentary  »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

07:55
10/22/19
10/22
07:55
10/22/19
07:55
General news
U.S. chain store sales rebounded 3.1% in the October 19 week »

U.S. chain store sales…

07:55
10/22/19
10/22
07:55
10/22/19
07:55
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

FBP

First BanCorp

$10.24

-0.015 (-0.15%)

07:54
10/22/19
10/22
07:54
10/22/19
07:54
Earnings
First BanCorp reports Q3 EPS 21c, consensus 19c »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

SGEN

Seattle Genetics

$100.86

13.44 (15.37%)

07:53
10/22/19
10/22
07:53
10/22/19
07:53
Recommendations
Seattle Genetics analyst commentary  »

Seattle Genetics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 07

    Dec

LNXSF

Lanxess

$0.00

(0.00%)

07:51
10/22/19
10/22
07:51
10/22/19
07:51
Downgrade
Lanxess rating change  »

Lanxess downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNW

Genworth

$4.31

0.01 (0.23%)

07:51
10/22/19
10/22
07:51
10/22/19
07:51
Hot Stocks
Genworth receives feedback from Canadian regulators regarding transaction »

Genworth Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

TREE

LendingTree

$317.86

3.4 (1.08%)

07:48
10/22/19
10/22
07:48
10/22/19
07:48
Recommendations
LendingTree analyst commentary  »

LendingTree price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 13

    Nov

  • 19

    Nov

EQM

EQT Midstream Partners

$32.99

-0.2 (-0.60%)

, EQT

EQT Corporation

$9.54

-0.175 (-1.80%)

07:48
10/22/19
10/22
07:48
10/22/19
07:48
Hot Stocks
EQT Midstream Partners-owned MVP says project work will be 90% complete by 2020 »

Mountain Valley announced…

EQM

EQT Midstream Partners

$32.99

-0.2 (-0.60%)

EQT

EQT Corporation

$9.54

-0.175 (-1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 05

    Nov

SNN

Smith & Nephew

$43.65

-4.165 (-8.71%)

07:48
10/22/19
10/22
07:48
10/22/19
07:48
Recommendations
Smith & Nephew analyst commentary  »

Smith & Nephew CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMC

Vulcan Materials

$146.64

0.5 (0.34%)

07:47
10/22/19
10/22
07:47
10/22/19
07:47
Initiation
Vulcan Materials initiated  »

Vulcan Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BBIO

BridgeBio

$18.54

0.29 (1.59%)

07:47
10/22/19
10/22
07:47
10/22/19
07:47
Hot Stocks
BridgeBio announces presentation of data from subsidiaries studies »

BridgeBio Pharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEL

TE Connectivity

$93.74

0.885 (0.95%)

07:45
10/22/19
10/22
07:45
10/22/19
07:45
Initiation
TE Connectivity initiated  »

TE Connectivity initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

MBRX

Moleculin Biotech

$1.07

-0.005 (-0.47%)

07:45
10/22/19
10/22
07:45
10/22/19
07:45
Hot Stocks
Moleculin Biotech raises Annamycin production »

Moleculin Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEP

NextEra Energy Partners

$51.04

-0.54 (-1.05%)

07:43
10/22/19
10/22
07:43
10/22/19
07:43
Earnings
Breaking Earnings news story on NextEra Energy Partners »

NextEra Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 04

    Dec

AX

Axos Financial

$29.97

0.54 (1.83%)

07:43
10/22/19
10/22
07:43
10/22/19
07:43
Hot Stocks
Newbridge Securities enters five-year clearing agreement with Axos Clearing »

Newbridge Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 06

    Nov

  • 04

    Dec

  • 05

    Dec

CVA

Covanta

$17.06

0.31 (1.85%)

07:42
10/22/19
10/22
07:42
10/22/19
07:42
Downgrade
Covanta rating change  »

Covanta double downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

APH

Amphenol

$100.40

1.35 (1.36%)

07:42
10/22/19
10/22
07:42
10/22/19
07:42
Initiation
Amphenol initiated  »

Amphenol initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

MAIN

Main Street

$42.50

0.23 (0.54%)

07:41
10/22/19
10/22
07:41
10/22/19
07:41
Downgrade
Main Street rating change  »

Main Street downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

ASND

Ascendis Pharma

$103.39

4.25 (4.29%)

, OPK

Opko Health

$2.12

0.03 (1.44%)

07:40
10/22/19
10/22
07:40
10/22/19
07:40
Recommendations
Ascendis Pharma, Opko Health, Pfizer analyst commentary  »

Ascendis Pharma price…

ASND

Ascendis Pharma

$103.39

4.25 (4.29%)

OPK

Opko Health

$2.12

0.03 (1.44%)

PFE

Pfizer

$36.45

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 06

    Nov

  • 07

    Dec

CPE

Callon Petroleum

$3.71

-0.12 (-3.13%)

, CRZO

Carrizo Oil & Gas

$7.29

-0.18 (-2.41%)

07:40
10/22/19
10/22
07:40
10/22/19
07:40
Hot Stocks
Callon Petroleum files presentation highlighting benefits of Carrizo deal »

Callon Petroleum Company…

CPE

Callon Petroleum

$3.71

-0.12 (-3.13%)

CRZO

Carrizo Oil & Gas

$7.29

-0.18 (-2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 14

    Nov

  • 14

    Nov

BAND

Bandwidth

07:39
10/22/19
10/22
07:39
10/22/19
07:39
Upgrade
Bandwidth rating change  »

Bandwidth upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

ARCC

Ares Capital

$18.70

0.14 (0.75%)

07:39
10/22/19
10/22
07:39
10/22/19
07:39
Downgrade
Ares Capital rating change  »

Ares Capital downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

FRPT

Freshpet

$49.68

0.05 (0.10%)

07:39
10/22/19
10/22
07:39
10/22/19
07:39
Upgrade
Freshpet rating change  »

JPMorgan upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

  • 19

    Nov

  • 20

    Nov

CHCO

City Holding

$79.30

1.94 (2.51%)

07:39
10/22/19
10/22
07:39
10/22/19
07:39
Earnings
City Holding reports Q3 EPS $1.36, consensus $1.32 »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.